Copy
View this email in your browser
Reserve Your Spot
The role of philanthropy in defeating COVID-19 is evolving and the needs are as great as ever. While philanthropists are eager to resume a "normal funding strategy", there are still critical gaps in our nation's response even with vaccines now available. Low-income communities and communities of color will continue to struggle to control infections and receive adequate medical care because of healthcare inequities and systemic racism. Philanthropists must continue to play a critical role in ensuring our fight against COVID-19 is an equitable one.

During this discussion, hear firsthand about the challenges facing underserved communities, and how philanthropists are addressing:
  • Unfunded critical needs at the national, state and community level.
  • The need for disruptive philanthropy that moves the needle in a significant way.
Who should attend? Individual donors, family offices, foundations and financial advisors who want to learn more about the urgent and evolving needs of the COVID-19 pandemic.

Speakers

Tom Kalil
Chief Innovation Officer
Schmidt Futures

Tom Kalil serves as Chief Innovation Officer for Schmidt Futures. In that capacity, he has supported initiatives related to the pandemic, such as increasing the supply of PPE, investing in COVID-related biomedical research, and strengthening the COVID response of our nation’s governors. Prior to Schmidt Futures, Tom served in the White House for two Presidents (Obama and Clinton), helping to design and launch national science and technology initiatives in areas such as nanotechnology, the BRAIN initiative, data science, materials by design, robotics, commercial space, high-speed networks, access to capital for startups, high-skill immigration, STEM education, learning technology, startup ecosystems, and the federal use of incentive prizes. Read Full Bio
 
Syra Madad
D.H.Sc., M.Sc., MCP
NYC Health & Hospitals, Special Pathogens Program

Syra Madad, D.H.Sc., M.Sc., MCP is a nationally recognized leader and epidemiologist in public health and special pathogen preparedness and response. She is Senior Director, System-wide Special Pathogens Program at New York City Health + Hospitals, the nation’s largest municipal healthcare delivery system overseeing special pathogen preparedness and response efforts across 11 acute care hospitals in addition to post-acute/long-term care facilities and ambulatory care sites. She is Principal Investigator of NYC Health + Hospitals Center for Global Healthcare Preparedness to Special Pathogens. Dr. Madad is also an Adjunct Senior Fellow of the Federation of American Scientists and part of their COVID-19 Expert Taskforce. Read Full Bio
 
Jennifer Nuzzo
DrPH, SM
Johns Hopkins Center for Health Security

Jennifer Nuzzo, DrPH, M.Sc is a Senior Scholar at the Johns Hopkins Center for Health Security, an Associate Professor in the Department of Environmental Health and Engineering and the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, and a Senior Fellow for Global Health at the Council on Foreign Relations. She directs the Outbreak Observatory, which conducts operational research to improve outbreak preparedness and response. Dr. Nuzzo is also the lead epidemiologist for the Johns Hopkins COVID-19 Testing Insights Initiative housed within the Johns Hopkins Coronavirus Resource Center. Read Full Bio
 
Sharon Knight
Executive Director
Stop the Spread
 
Sharon Knight leads Stop the Spread's mission to meet the needs of underserved communities during the COVID crisis. Sharon has led diverse functions and multi-national teams at both Fortune 500 and venture capital-backed companies for 20+ years. Prior to joining Stop the Spread, Sharon was the President and COO of Hawthorne Effect, which was created to democratize clinical trials, improving access and diversity while ensuring comprehensive data collection. Read Full Bio
 
Margret Trilli (Moderator)
Chief Executive Officer and Chief Investment Officer
ImpactAssets

Margret Trilli serves as CEO and CIO for ImpactAssets. Since the beginning of the COVID-19 pandemic, Margret has led the ImpactAssets COVID Response Program, designed to activate philanthropists and impact investors to address the critical gaps between public and private response to the pandemic. 
Read Full Bio
We hope you'll join us for this urgent discussion on the important role philanthropy can play to end the COVID-19 pandemic.
Reserve Your Spot
Questions about this event? Contact events@impactassets.org.
About the ImpactAssets Stop the Spread COVID Response Program
The ImpactAssets Stop the Spread COVID Response Program (The Program) is the convergence of an impact investing and private sector response to solving the immediate and evolving needs of COVID-19. The Program harnesses the collective power of ImpactAssets’ leading impact investment and organizational capacity and Stop the Spread’s agile partnership model connecting and catalyzing the private and public sector response to COVID-19. In the immediate term, combined forces are addressing acute frontline healthcare needs by helping companies access knowledge and connections to spur rapid production of PPE. Identified models of critical-needs innovation are connected to investment capital through the ImpactAssets Stop the Spread Fund, a philanthropic impact investing fund addressing frontline COVID healthcare and PPE needs. By bringing together a community of 1,300+ CEO’s and Executives, supporting volunteers, donors, subject-matter experts and an investment pipeline of 400+ potentially promising COVID initiatives, The Program strengthens our COVID Response.

About ImpactAssets
ImpactAssets is the leading impact investing partner for individuals, families and philanthropists tackling the world’s greatest challenges by investing in the world’s brightest ideas. We make it easy for our clients to “discover, connect and invest” in game-changing entrepreneurs and funds. Founded in 2010, ImpactAssets increases flows of money to impact investing with our 100% impact investment platform and field-building initiatives, including the IA50 database of private debt and equity impact fund managers. The ImpactAssets Donor Advised Fund is an innovative vehicle that empowers donors to increase the impact of their giving by combining it with strategic sustainable and responsible investing to build a sophisticated philanthropic endowment. The Fund currently has more than $1.2 billion in assets in 1,400 donor advised funds, working with 350 wealth advisors across 60 financial services firms.
 
Connect with us on social media.
Like Like
Follow Follow
Connect Connect
Watch Watch
Learn Learn
LEGAL AND PROGRAM DISCLAIMER: This is not a solicitation to buy or sell securities, nor a private placement offering pursuant to any private placement memorandum that must be issued to qualified investors.
Copyright © 2021 ImpactAssets, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.